Xenon Pharmaceuticals Inc (XENE)

43.75 +0.75 (+1.74%) USD  |  NASDAQ  |  May 03, 16:00
43.75 0.00 (0.00%) After-Hours: 20:00
More

Xenon Pharmaceuticals Research and Development Expense (Quarterly): 41.08M for Dec. 31, 2023

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.
Date Value
December 31, 2023 41.08M
September 30, 2023 42.88M
June 30, 2023 44.04M
March 31, 2023 39.52M
December 31, 2022 34.83M
September 30, 2022 29.43M
June 30, 2022 22.15M
March 31, 2022 19.36M
December 31, 2021 21.89M
September 30, 2021 18.89M
June 30, 2021 18.38M
March 31, 2021 16.31M
December 31, 2020 14.97M
September 30, 2020 13.04M
June 30, 2020 10.72M
March 31, 2020 11.79M
December 31, 2019 11.75M
September 30, 2019 9.751M
June 30, 2019 8.205M
March 31, 2019 9.137M
December 31, 2018 6.402M
Date Value
September 30, 2018 6.248M
June 30, 2018 5.416M
March 31, 2018 5.568M
December 31, 2017 6.397M
September 30, 2017 7.164M
June 30, 2017 6.109M
March 31, 2017 5.903M
December 31, 2016 4.396M
September 30, 2016 5.965M
June 30, 2016 5.103M
March 31, 2016 4.364M
December 31, 2015 4.263M
September 30, 2015 3.793M
June 30, 2015 3.669M
March 31, 2015 3.427M
December 31, 2014 3.453M
September 30, 2014 3.216M
June 30, 2014 2.566M
March 31, 2014 2.533M
December 31, 2013 2.743M
September 30, 2013 2.577M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

8.205M
Minimum
Jun 2019
44.04M
Maximum
Jun 2023
22.58M
Average
18.89M
Median
Sep 2021

Research and Development Expense (Quarterly) Benchmarks

Acasti Pharma Inc 1.443M
Aurinia Pharmaceuticals Inc 10.23M
Edesa Biotech Inc 0.7045M
Lexaria Bioscience Corp 0.2458M
ESSA Pharma Inc 5.377M